Roche voluntarily let the Herceptin patent lapse

Mint
Mint
  • 6 years ago
Swiss drug maker Roche Holding AG, which missed a patent renewal deadline for its Herceptin has said that it was voluntary decision to let it lapse. Mint's CH Unnikrishnan explains the company's game plan

Recommended

Transformation Agenda 2020 by Mint and Danfoss : India's climate imperatives
Mint
3:14
Interview: Manipur's, Chief Electoral Officer, P.C. Lawkunga
Mint
2:23
Closing Bell
Mint
3:09
Deals Space
Mint
2:09
Tough times ahead for firms with high leverage
Mint
1:53
Marriages and Indonesia’s Food Waste Problem
Mint
1:28
Trump meets Singapore PM ahead of historic Summit with Kim Jong Un
Mint
1:41
The rise, fall and return of Jagmohan Dalmiya
Mint
1:51
Bihar polls: Modi, Nitish Kumar make last-minute push with 10 rallies
Mint
2:26
Closing Bell
Mint
0:32
Growth of net sales slowest since Q4 FY09
Mint
1:15
Key trends in how India’s rich invest in equities
Mint
19:21
Mint Presents Market this week
Mint
1:28
Tata's initiatives to preserve culture
Mint
5:36
Growth momentum to continue in Q2, H2 due to trastuzumab launch, says Biocon
CNBC-TV18

Mint

6:52
Jet Airways crisis: Who is to blame, lending banks or promoter Naresh Goyal?
Mint
1:38
What to expect from Reliance Q4 earnings?
Mint
29:58
Zia Mody on adversarial deal making, fear of missing out in private equity
Mint
19:20
Apex Court squashes RBI's Feb 12 Circular on Stressed Assets Resolution : A Decode
Mint
12:50
Marico Founder Harsh Mariwala on how Indian start-ups can scale up & thrive
Mint
23:10
'Hostile' takeovers: L&T-Mindtree saga signals new era in Indian M&A deals?
Mint

Featured channels

More from
HW News Network
More from
OutlookIndia
More from
HW News English
More from
HW News Marathi
More from
Comedy Tadka
More from
Tuk Tuk TV